Skip to main content
. 2023 Jan 12;39:100579. doi: 10.1016/j.ctro.2023.100579

Table 4.

Univariate and multivariate Cox regression analysis of variables predicting disease-free survival (DFS).

VARIABLE Events, n (%) UNIVARIATE MULTIVARIATE
GENDER
Male
Female

207 (42.2)
111 (35.5)
p = 0.16
1.18 (0.94–1.48)
1.00
AGE, years
<65
≥65

131 (32.5)
187 (46.6)
p < 0.0001
1.00
1.68 (1.342.10)
p = 0.002
1.00
1.49 (1.161.94)
cT
1–2
3
4

27 (46.6)
214 (38.7)
72 (42.9)
p = 0.16
1.00
0.74 (0.50–1.10)
0.90 (0.58–1.40)
cN
negative
positive

53 (34.4)
264 (41.2)
p = 0.034
1.00
1.38 (1.021.86)
---
EXTRAMESORECTAL NODES
no
yes

198 (34.8)
80 (48.5)
p < 0.0001
1.00
1.59 (1.232.07)
p = 0.02
1.00
1.42 (1.071.88)
CONCOMITANT CT
single agent
double agent

239 (40.4)
69 (34.3)
p = 0.15
1.00
0.82 (0.63–1.07)
RT, Gy
<55
≥55

116 (36.6)
202 (41.5)
p = 0.002
1.00
1.44 (1.141.82)
p = 0.008
1.00
1.46 (1.101.94)
SURGICAL INTERVAL, weeks
<12
≥12

176 (39.6)
120 (37.6)
p = 0.030
1.00
1.30 (1.031.66)
---
NLR
<=2.5
>2.5

158 (38.6)
160 (40.5)
p = 0.69
1.00
1.05 (0.84–1.30)
PLR
<=100
>100

60 (35.9)
258 (40.5)
p = 0.52
1.00
1.10 (0.83–1.45)
SII
<=500
>500

118 (40.0)
200 (39.3)
p = 0.89
1.00
1.02 (0.81–1.27)
MLR
<=0.18
>0.18

52 (29.1)
266 (42.6)
p = 0.01
1.00
1.46 (1.081.97)
p = 0.03
1.00
1.43 (1.021.99)
HEI
0–1-2
3

267 (38.3)
51 (48.1)
p = 0.009
1.00
1.49 (1.112.01)
p = 0.05
1.00
1.35 (1.001.87)

CT: chemotherapy; Gy: Gray; HEI: hemo-eosinophils inflammation index; MLR: monocyte-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; RT: radiotherapy; SII: systemic index of inflammation. In bold the statistically significant values.